TLX · Telix Pharmaceuticals Ltd
Market Cap
$4.06B
Shares
339.78M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-09-22 16:30 UTC | Telix 2026 R&D Day 2026 (New York City) | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-19 | Telix H1 2026 Results Webcast | Earnings call |
| 2026-06-29 | Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions | Event |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-02 | William Blair 46th Annual Growth Stock Conference | Conference |
| 2026-04-30 | Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach | Event |
| 2026-03-17 | HCW @ Home with Telix Pharmaceuticals | Event |
| 2026-02-20 | Earnings conference call (announced in 6-K) | Earnings call |
Source: https://ir.telixpharma.com/
Key facts
CIK
2007191
CUSIP
87961M105
13F (30d)
41 filings
41 filers
Visit website
Investor relations